Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-1136|66|3|492-504

ISSN： 0894-1491

Source： GLIA, Vol.66, Iss.3, 2018-03, pp. : 492-504

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revisiting the peripheral sink hypothesis: inhibiting BACE1 activity in the periphery does not alter β‐amyloid levels in the CNS

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 132, Iss. 4, 2015-02 ,pp. : 477-486

John Wiley & Sons Inc

Access to resources Recommend Favorite

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma

By Ahn Brian J.   Pollack Ian F.   Okada Hideho  

Cancers, Vol. 5, Iss. 4, 2013-11 ,pp. : 1379-1412

MDPI

Access to resources Recommend Favorite

Amyloid-β and Astrocytes Interplay in Amyloid-β Related Disorders

By Batarseh Yazan S.   Duong Quoc-Viet   Mousa Youssef M.   Al Rihani Sweilem B.   Elfakhri Khaled   Kaddoumi Amal  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 338-338

MDPI

Access to resources Recommend Favorite

Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation

By Hane Francis   Leonenko Zoya  

Biomolecules, Vol. 4, Iss. 1, 2014-01 ,pp. : 101-116

MDPI

Access to resources Recommend Favorite

NMDA and AMPA Receptors in Transgenic Mice Expressing Human β‐Amyloid Protein

By  

JOURNAL OF NEUROCHEMISTRY (ELECTRONIC), Vol. 61, Iss. 6, 1993-12 ,pp. : 2286-2289

John Wiley & Sons Inc

Access to resources Recommend Favorite